Skip to main content
Swiss Re AG logo

Swiss Re AG — Investor Relations & Filings

Ticker · SREN ISIN · CH0126881561 LEI · 529900PS9YW3YY29F326 SW Financial and insurance activities
Open in API
Filings indexed 325 across all filing types
Latest filing 2024-11-07 Earnings Release
Country CH Switzerland
Listing SW SREN

About Swiss Re AG

https://www.swissre.com/

Swiss Re AG is a leading wholesale provider of reinsurance, insurance, and other insurance-based forms of risk transfer. The company's core business is structured into several segments, including Property & Casualty Reinsurance, Life & Health Reinsurance, and Commercial Insurance solutions for corporate clients. It also offers Risk Data Solutions to help insurers, corporations, and governments navigate complex risks with greater precision. By absorbing significant risks, from natural catastrophes and climate change to pandemics and cybercrime, the company aims to make the world more resilient, enabling its clients and society to thrive and progress.

Recent filings

Filing Released Lang Actions
Swiss Re strengthens US liability reserves, following a comprehensive reserve review
Earnings Release Classification · 100% confidence The document is titled 'Ad hoc announcement pursuant to Art. 53 LR' and details specific financial updates, namely the strengthening of US liability reserves by USD 2.4 billion in Q3 2024 and expected Group net income for Q3. This content—a preliminary release of key financial figures and strategic decisions before the full quarterly report—aligns perfectly with the definition of an Earnings Release (ER). Although it mentions the full results will be published later (Nov 14), this document itself is the initial announcement of the period's performance highlights. Q3 2024
2024-11-07 English
Swiss Re stärkt Rückstellungen für US-Haftpflichtgeschäft nach einer umfassenden Überprüfung der Reserven
Earnings Release Classification · 100% confidence The document is explicitly titled "Ad hoc-Mitteilung gemäss Art. 53 KR" (Ad hoc announcement according to Art. 53 KR) and is published by Swiss Re Ltd. It details significant, non-public information regarding strengthening reserves for US casualty business and provides preliminary Q3/9M 2024 profit expectations. This type of immediate, material disclosure required by regulatory bodies (like SIX Swiss Exchange rules, indicated by 'KR') is typically classified as a general regulatory announcement or a specific type of earnings/material event disclosure. Since it is an immediate, unscheduled announcement of material information rather than a scheduled comprehensive report (like 10-K or IR) or a formal earnings release (ER) which usually follows a strict format, it fits best under the general regulatory filing category, RNS, as it is an 'Ad hoc' disclosure. However, given the content heavily focuses on preliminary financial results and outlook adjustments (profit expectations, P&C Re combined ratio outlook), it shares characteristics with an Earnings Release (ER) or Management Discussion & Analysis (MDA). Since it is an unscheduled, ad-hoc disclosure of material financial impact, and not the full quarterly report (IR) or the formal press release summarizing results (ER), RNS serves as the most appropriate catch-all for mandatory, unscheduled regulatory disclosures that don't fit the specific financial report codes. 9M 2024
2024-11-07 German
Swiss Re agrees to sell iptiQ's European P&C business to Allianz Direct
M&A Activity Classification · 99% confidence The document is a press release dated November 5, 2024, announcing that Swiss Re agrees to sell iptiQ’s European P&C business to Allianz Direct. This clearly describes a corporate action related to a merger or acquisition (M&A) activity. The keyword 'Mergers & Acquisitions' is explicitly listed in the metadata section. This aligns directly with the definition for M&A Activity (TAR). Although it is a news release, the core subject matter is the transaction itself, not just the announcement of a report, making TAR a more specific fit than RPA or RNS.
2024-11-05 English
Swiss Re agrees to sell iptiQ's European P&C business to Allianz Direct
M&A Activity Classification · 98% confidence The document is a press release dated 05.11.2024 announcing that Swiss Re has agreed to sell a part of its iptiQ business to Allianz Direct. The key subject is a major corporate transaction involving the sale of a business unit, which falls under Mergers & Acquisitions (M&A) activity. Based on the provided definitions, the code 'TAR' (M&A Activity) is the most appropriate classification. The document is a formal announcement of a transaction, not a full regulatory report like a 10-K or IR.
2024-11-05 English
Swiss Re einigt sich über Verkauf des europäischen P&C-Geschäfts von iptiQ an Allianz Direct
M&A Activity Classification · 99% confidence The document is a press release from Swiss Re dated November 5, 2024, announcing an agreement to sell a part of its business (iptiQ's European P&C business) to Allianz Direct. The key phrases are "Schlagwort(e): Fusionen & Übernahmen" (Keywords: Mergers & Acquisitions) and the content details the sale/acquisition of an insurance carrier and its business lines. This clearly falls under the category of M&A Activity (TAR). It is not a formal regulatory filing like a 10-K, nor is it a general earnings release or a short announcement of a report (RPA/RNS), but rather the substantive announcement of a major corporate transaction.
2024-11-05 German
Covid-19 may lead to longest period of peacetime excess mortality, says new Swiss Re report
Environmental & Social Information Classification · 99% confidence The document is dated 16.09.2024 and is titled as a 'Research Update' from Swiss Re, summarizing findings from the 'Swiss Re Institute's report The future of excess mortality after COVID-19'. It provides key findings, quotes from management, and implications for insurers. It is not a full Annual Report (10-K), a formal Earnings Release (ER) with standardized financial tables, or a Call Transcript (CT). It is a summary of research findings intended for investors and the public. Since it is a detailed summary of a specific report/study, it aligns best with an Investor Presentation (IP) or a general informational release. Given the context of a 'Research Update' summarizing a proprietary report, 'Investor Presentation' (IP) is the most fitting category, as these documents often present research findings to the investment community. It is not a short announcement about a report being available, so RPA/RNS is less appropriate than IP.
2024-09-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.